These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 220988)

  • 1. Central nervous system lupus erythematosus: measurement of cerebrospinal fluid cyclic GMP and other clinical markers of disease activity.
    Kassan SS; Kagen LJ
    Arthritis Rheum; 1979 May; 22(5):449-57. PubMed ID: 220988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of cerebrospinal fluid guanosine 3',5'-cyclic monophosphate (C-GMP) in systemic lupus erythematosus.
    Kassan SS; Kagen LJ
    Am J Med; 1978 May; 64(5):732-41. PubMed ID: 206141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus.
    Jara LJ; Irigoyen L; Ortiz MJ; Zazueta B; Bravo G; Espinoza LR
    Clin Rheumatol; 1998; 17(2):110-4. PubMed ID: 9641506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis.
    Sergent JS; Lockshin MD; Klempner MS; Lipsky BA
    Am J Med; 1975 May; 58(5):644-54. PubMed ID: 1130420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
    Hirohata S; Hirose S; Miyamoto T
    Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.
    Hirohata S; Miyamoto T
    Arthritis Rheum; 1990 May; 33(5):644-9. PubMed ID: 2346520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can determination of lactic acid and pyruvic acid in cerebrospinal fluid help in diagnosing central nervous system involvement in systemic lupus erythematosus?
    Duinkerke SJ; Gabreëls FJ; Boerbooms AM; Kok JC; Renier WO
    Clin Neurol Neurosurg; 1983; 85(4):225-30. PubMed ID: 6317249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS lupus.
    Bresnihan B
    Clin Rheum Dis; 1982 Apr; 8(1):183-95. PubMed ID: 6749393
    [No Abstract]   [Full Text] [Related]  

  • 9. Balance between inflammatory and regulatory cytokines in systemic lupus erythematosus.
    Yao Y; Wang JB; Xin MM; Li H; Liu B; Wang LL; Wang LQ; Zhao L
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
    Kelly MC; Denburg JA
    J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
    Trysberg E; Blennow K; Zachrisson O; Tarkowski A
    Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.
    Bluestein HG; Williams GW; Steinberg AD
    Am J Med; 1981 Feb; 70(2):240-6. PubMed ID: 7468611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial CSF immunoglobulins in CNS SLE.
    Temesvári P
    J Rheumatol; 1988 Oct; 15(10):1592. PubMed ID: 3204609
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
    Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
    Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance imaging and cerebrospinal fluid examinations in a case of central nervous involvement of systemic lupus erythematosus].
    Tamura K; Take H; Kurabayashi H; Kubota K; Shirakura T
    Nihon Ronen Igakkai Zasshi; 1994 Jul; 31(7):554-7. PubMed ID: 7933661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers.
    Alcocer-Varela J; Aleman-Hoey D; Alarcon-Segovia D
    Lupus; 1992 Feb; 1(2):111-7. PubMed ID: 1301962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.